Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
The FDA has accepted a new drug application (NDA) for zipalertinib for the treatment of patients with locally advanced or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results